Cellebrite DI annual return on equity
2020
2022
2023
2024
2025
Cellebrite DI Return on Equity (ROE) Growth & History (CLBT)
Cellebrite DI's return on equity was 19.10% for fiscal 2025.
View full Cellebrite DI company overviewCellebrite DI annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 19.10% | +171.98 pp |
| 2024 | 2024-12-31 | −152.88% | −2.80 pp |
| 2023 | 2023-12-31 | −150.08% | −46792.94 pp |
| 2022 | 2022-12-31 | 46,642.86% | — |
| 2020 | 2020-12-31 | 9.43% | — |
Cellebrite DI quarterly return on equity
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.22% | −3.83 pp |
| Q1 2026 | 2026-03-31 | 2.20% | −2.78 pp |
| Q4 2025 | 2025-12-31 | 4.56% | — |
| Q3 2025 | 2025-09-30 | 4.72% | — |
| Q2 2025 | 2025-06-30 | 5.05% | — |
| Q1 2025 | 2025-03-31 | 4.97% | — |
Cellebrite DI return on equity trends
Over the last five fiscal years, Cellebrite DI's return on equity increased from 9.43% to 19.10%, a change of +9.67 percentage points. The latest reported quarter, Q2 2026, shows 1.22%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellebrite DI source filings ↗